Dna X (SONM) Accounts Payables (2018 - 2026)

Dna X's Accounts Payables history runs 9 years deep, the most recent figure standing at $719000.0 for Q1 2026.

• Quarterly Accounts Payables fell 95.84% year-over-year to $719000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $719000.0 (down 95.84% YoY) and the FY2025 annual result came in at $4.0 million, up 446.07% from the prior year.
• Accounts Payables was $719000.0 for Q1 2026 at Dna X, down from $4.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $23.3 million in Q3 2023 and bottomed at $719000.0 in Q1 2026.
• A 5-year average of $13.6 million and a median of $13.4 million in 2022 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2024 — Accounts Payables tumbled 96.28% — and 2025, when it surged 446.07%.
• Dna X's Accounts Payables stood at $21.1 million in 2022, then declined by 6.05% to $19.8 million in 2023, then tumbled by 96.28% to $738000.0 in 2024, then jumped by 446.07% to $4.0 million in 2025, then slumped by 82.16% to $719000.0 in 2026.
• Business Quant data shows SONM's Accounts Payables at $719000.0 in Q1 2026, $4.0 million in Q4 2025, and $20.4 million in Q3 2025.